An in-depth look to FUSEN PHARMACEUTICAL CO LTD operating, investing, and financing activities

1652 free cash flow for H1 24 is -56.62 M HKD. For 2023, 1652 free cash flow was -176.16 M HKD and operating cash flow was -102.96 M HKD.